Analyses showed that several commercialized follow-on oral semaglutide DPs had a markedly lower quantity of semaglutide than the label claim, while dissolution tests indicated different semaglutide and sodium N-(8-[2-hydroxybenzoyl] amino)caprylate (SNAC) release profiles, which may reduce bioavailability
DiStefano, Ph.D., from University of Colorado Anschutz, and colleagues characterized available compounded GLP-1 RA products offered by weight-loss clinics and medical spas, described aspects of patient care and monitoring, and identified characteristics of compounding suppliers
Still, experts caution that the research is evolving, and GLP-1 drugs are not currently approved as treatments for addiction
LUPKIN: Instead of trying to figure out how many customers were ordering doses, she decided to look further up the supply chain
Aim to drink at least half of your weight in ounces of filtered water